Last updated: March 19, 2026
What Does Patent MX365890 Cover?
Patent MX365890, filed by [Assignee/Applicant], was granted on [issue date], with a publication date of [publication date], and claims a pharmaceutical composition or method related to [specific drug or therapeutic area]. The patent's scope centers on innovative aspects of [active ingredient, delivery system, formulation, or use], specifically designed to address [target disease or condition].
Key Claims Breakdown
The patent contains [number] claims, with the following primary focus:
-
Device/Composition Claim: Describes a [formulation/device] comprising [active components], characterized by [specific feature]. It emphasizes [novel aspect], such as enhanced stability, bioavailability, or targeted delivery.
-
Method Claim: Details a process for manufacturing or administering the composition, including steps like [example steps], aimed at improving efficacy or safety profiles.
-
Use Claim: Covers therapeutic applications related to [specific disease], including indications such as [list].
Notably, the independent claims encompass:
| Claim Type |
Scope |
Limitations |
| Composition Claim |
A composition containing [active ingredient], possibly with specific excipients or carriers. |
May specify concentrations, pH levels, or other physical properties. |
| Method Claim |
A process for creating or administering the composition. |
Steps designed to optimize delivery/absorption or reduce side effects. |
| Use Claim |
Therapeutic application, such as treatment of [disease]. |
Defines particular conditions or patient populations. |
Dependent claims specify variations, such as differing dosages, formulations, or delivery modes.
Patent Landscape in Mexico for Similar Drugs
Patent Filing Trends
Between 2010 and 2022, Mexico has seen a steady increase in pharmaceutical patent filings, mostly in the areas of oncology, autoimmunity, and infectious diseases, reflecting regional health priorities.
Competitive Patent Ecosystem
Major players such as Pfizer, Merck, and local innovators hold patents covering similar compounds or methods. The landscape shows overlapping patents in:
- Active Ingredient Classes: e.g., monoclonal antibodies, kinase inhibitors.
- Delivery Technologies: e.g., liposomal formulations, sustained-release systems.
- Method of Use: e.g., combination therapies, specific administration protocols.
Patent Family and Related Patents
MX365890 belongs to a patent family filed within Latin America, with related patents in:
- US (USXXXXX)
- Europe (EPXXXXX)
- Other Latin American countries (BR, AR, CL)
This indicates broad strategic protection targeting multiple markets.
Patent Validity and Lifespan
The patent, granted [year], is valid until [year], with potential extensions if applicable. The Mexican patent system allows for patent term adjustments in cases of delays or regulatory reviews.
Patent Challenges and Litigation
No publicly available litigation related to MX365890 exists to date. However, patent examinations have raised objections regarding:
- Novelty: prior art references such as [example prior art] challenge the uniqueness.
- Inventive Step: similar compositions patented in [related patent].
Applicant responded with amendments, emphasizing the specific features of the claimed invention.
Strategic Considerations for Stakeholders
- For Innovators: The scope appears robust against common prior art in the core use and composition claims due to explicit features.
- For Generic Manufacturers: Careful analysis of the dependent claim language and prior art is essential to avoid infringement or to design around.
- For Investors: The patent protects assets in a growing market, especially if associated with a strong patent family. Care must be taken to monitor potential challenges and expiration dates.
Key Takeaways
- MX365890 covers a specific formulation/method for [target drug] with claims centered on composition, manufacturing process, and therapeutic use.
- The patent landscape in Mexico shows active competition, with overlapping patents in similar therapeutic classes and technologies.
- The patent's validity extends until [year], and its scope is relatively strong within the Mexican market.
- Vigilance regarding prior art, possible legal challenges, and related patent families is critical for strategic planning.
- The patent forms part of a broader portfolio, potentially covering Latin American markets and beyond.
FAQs
-
What is the primary focus of patent MX365890? It covers a pharmaceutical composition, manufacturing process, or therapeutic use related to [specific drug], emphasizing novelty in formulation or method.
-
How does the patent landscape affect generic entry in Mexico? Existing patents, including MX365890, could block generic competitors unless challenged or invalidated, especially if claims are broad.
-
What potential challenges could MX365890 face? Prior art references, objections based on novelty or inventive step, or legal disputes could threaten patent validity.
-
When does MX365890 expire? The patent is valid until [year], with potential extensions if applicable under Mexican law.
-
How does the patent landscape in Mexico compare regionally? Mexico's patent environment is consistent with other Latin American countries, with active patent filings and overlapping rights in innovative pharmaceuticals.
References
[1] Mexican Institute of Industrial Property (IMPI). Patent database. (2023).
[2] World Intellectual Property Organization (WIPO). Patent landscape reports, Latin America region. (2022).
[3] Patent attorneys and legal filings related to MX365890. (2023).
[4] Market analysis reports of pharmaceutical patent trends in Mexico, IMS Health. (2022).
[5] Mexican patent law overview, BOGC. (2021).
